So, the natural expectation now that Medtronic has backed out of their deal to buy EOFlow is who’s next up. Medtronic foolishly wants to be in the patch pump business, when they really should be getting out of diabetes, so who’s next. Why not Embecta as they have a way cool whiz bang patch pump for Type 2 patients. Or what about our friends here in San Diego Modular Medical. Maybe they should cross the pond and buy Kaleido. What about Medtrum I think they’re still in business.
Seriously Medtronic reminds me of a drunken sailor who . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.